Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
7.92
-0.15 (-1.86%)
At close: Apr 28, 2026, 4:00 PM EDT
7.97
+0.05 (0.63%)
After-hours: Apr 28, 2026, 7:59 PM EDT
Novavax Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Novavax stock have an average target of 11.33, with a low estimate of 6.00 and a high estimate of 19. The average target predicts an increase of 43.06% from the current stock price of 7.92.
Analyst Consensus: Hold
* Price targets were last updated on Feb 27, 2026.
Analyst Ratings
The average analyst rating for Novavax stock from 9 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 3 | 3 | 3 | 3 | 3 | 3 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $16 | Strong Buy | Maintains | $11 → $16 | +102.02% | Feb 27, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +139.90% | Jan 20, 2026 |
| JP Morgan | JP Morgan | Sell Maintains $7 → $6 | Sell | Maintains | $7 → $6 | -24.24% | Nov 18, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $18 → $16 | Strong Buy | Reiterates | $18 → $16 | +102.02% | Nov 10, 2025 |
| TD Cowen | TD Cowen | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | -11.62% | Nov 4, 2025 |
Financial Forecast
Revenue This Year
402.75M
from 1.12B
Decreased by -64.15%
Revenue Next Year
296.79M
from 402.75M
Decreased by -26.31%
EPS This Year
-0.41
from 2.58
EPS Next Year
-0.17
from -0.41
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 557.0M | 454.6M | ||||||
| Avg | 402.8M | 296.8M | ||||||
| Low | 245.5M | 107.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -50.4% | 12.9% | ||||||
| Avg | -64.2% | -26.3% | ||||||
| Low | -78.1% | -73.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 0.79 | 0.83 | |||||
| Avg | -0.41 | -0.17 | |||||
| Low | -1.31 | -1.16 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | -69.4% | - | |||||
| Avg | - | - | |||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.